Literature DB >> 12843756

Systematic screening of cryptococcal antigenemia in HIV-positive adults in Uganda.

Jean-Michel Tassie, Larry Pepper, Carole Fogg, Samuel Biraro, Bernard Mayanja, Irene Andia, André Paugam, Gérardo Priotto, Dominique Legros.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12843756     DOI： 10.1097/00126334-200307010-00019

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  15 in total

1.  Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings.

Authors:  David B Meya; Yukari C Manabe; Barbara Castelnuovo; Bethany A Cook; Ali M Elbireer; Andrew Kambugu; Moses R Kamya; Paul R Bohjanen; David R Boulware
Journal:  Clin Infect Dis       Date:  2010-08-15       Impact factor: 9.079

Review 2.  Integrating cryptococcal antigen screening and pre-emptive treatment into routine HIV care.

Authors:  Radha Rajasingham; David B Meya; David R Boulware
Journal:  J Acquir Immune Defic Syndr       Date:  2012-04-15       Impact factor: 3.731

Review 3.  Asymptomatic cryptococcemia in resource-limited settings.

Authors:  Ana-Claire Meyer; Mark Jacobson
Journal:  Curr HIV/AIDS Rep       Date:  2013-09       Impact factor: 5.071

4.  Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa.

Authors:  Joseph N Jarvis; Stephen D Lawn; Monica Vogt; Nonzwakazi Bangani; Robin Wood; Thomas S Harrison
Journal:  Clin Infect Dis       Date:  2009-04-01       Impact factor: 9.079

5.  Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.

Authors:  John R Perfect; William E Dismukes; Francoise Dromer; David L Goldman; John R Graybill; Richard J Hamill; Thomas S Harrison; Robert A Larsen; Olivier Lortholary; Minh-Hong Nguyen; Peter G Pappas; William G Powderly; Nina Singh; Jack D Sobel; Tania C Sorrell
Journal:  Clin Infect Dis       Date:  2010-02-01       Impact factor: 9.079

6.  Prevalence of cryptococcal antigenemia and cost-effectiveness of a cryptococcal antigen screening program--Vietnam.

Authors:  Rachel M Smith; Tuan Anh Nguyen; Hoang Thi Thanh Ha; Pham Hong Thang; Cao Thuy; Truong Xuan Lien; Hien T Bui; Thai Hung Le; Bruce Struminger; Michelle S McConnell; Robyn Neblett Fanfair; Benjamin J Park; Julie R Harris
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

Review 7.  Preventing Cryptococcosis-Shifting the Paradigm in the Era of Highly Active Antiretroviral Therapy.

Authors:  David Meya; Radha Rajasingham; Elizabeth Nalintya; Mark Tenforde; Joseph N Jarvis
Journal:  Curr Trop Med Rep       Date:  2015

Review 8.  New Insights into HIV/AIDS-Associated Cryptococcosis.

Authors:  Spinello Antinori
Journal:  ISRN AIDS       Date:  2013-02-25

9.  Comparison of cryptococcal antigenemia between antiretroviral naïve and antiretroviral experienced HIV positive patients at two hospitals in Ethiopia.

Authors:  Tafese Beyene; Yimtubezinash Woldeamanuel; Daniel Asrat; Gonfa Ayana; David R Boulware
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

10.  Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa.

Authors:  Joseph N Jarvis; Thomas S Harrison; Stephen D Lawn; Graeme Meintjes; Robin Wood; Susan Cleary
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.